Supervision et direction scientifique du Registre neuchâtelois et jurassien des tumeurs (RNJT)

2022

Di Carlo V., Stiller C.A., et al. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000–2014 in 59 countries (CONCORD-3)*. British Journal of Dermatology 187, no 3 (2022): 364‑80

Bulliard J.-L., Bovio N., et al. Occupational factors and socioeconomic differences in breast cancer risk and stage at diagnosis in Swiss working women. Cancers 14, no 15 (29 juillet 2022): 3713

Nikšić M., Matz M., et al. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000-2014 (CONCORD-3). Cancer Epidemiology 80 (1 octobre 2022): 102196

Ssenyonga N., Stiller C., et al. Worldwide trends in population-based survival for children, adolescents and young adults diagnosed with leukaemia, by subtype, during 2000-2014 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. The Lancet Child & Adolescent Health 6, no 6 (1 juin 2022): 409‑31

Montagna G., Schaffar R., et al. Management and outcome of young women (<=40 years) with breast cancer in Switzerland. Cancers 14, no 5 (janvier 2022): 1328

Plys, E., Bovio N., et al. Research on occupational diseases in the absence of occupational data: a mixed-method study among cancer registries of western Switzerland. Swiss Medical Weekly, no 7 (22 février 2022)

2021

Girardi F., Rous B., et al. The histology of brain tumours for 67,331 children and 671,085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro-Oncology 23, no 10 (1 octobre 2021): 1765‑76

Andres M., Feller A., et al. Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016. Swiss Medical Weekly, no 11 (15 mars 2021)

Contiero P., Tagliabue G., et al. Variation of Cancer Incidence between and within GRELL Countries. International Journal of Environmental Research and Public Health 18, no 17 (janvier 2021): 9262

2020

Alwan H., La Rosa S., et al. Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland. Cancer Medicine 9, no 24 (2020): 9454‑61

Feller A., Bopp M., et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Medical Weekly, no 5 (7 février 2020)

Feller A., Matthes K., et al. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer 20, no 1 (21 janvier 2020): 51 

2019

Kollár A., Rothermundt C., et al. Incidence, mortality and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer Epidemiology 63 (1 décembre 2019): 101596 

Rahban R., Priskorn L., et al. Semen quality of young men in Switzerland: an evaluation of geographic variations in a nationwide cross-sectional population-based study. Andrology 7, no 6 (2019): 818‑26

Andres M., Feller A., et al. Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016. A Population-Based Study. Swiss Medical Weekly, no 11 (15 mars 2021)

Bannon F., Di Carlo V., et al. Survival trends for primary liver cancer, 1995-2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 countries (CONCORD-2). Annals of Cancer Epidemiology 3, no 0 (20 septembre 2019)

2018

Allemani C., Matsuda T., et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet 391, no 10125 (17 mars 2018): 1023‑75 

2017

Bonaventure A., Harewood R., et al. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of data including 89828 children from 198 registries in 53 countries. The Lancet Haematology 4, no 5 (1 mai 2017): e202‑17

Matz M., Coleman M., et al. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).Gynecologic Oncology 144, no 2 (1 février 2017): 405‑13

Matz M., Coleman M., et al. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecologic Oncology 144, no 2 (1 février 2017): 396‑404